First-Line Therapy for Patients with Advanced Hodgkin’s Lymphoma: Efficacy and Toxicity of Intensive ЕАСОРР-14 Program (NN Blokhin National Medical Cancer Research Center Data)

Autor: YuI Pryamikova, Gayane Tumyan, EA Osmanov, AA Leont’eva, LV Manzyuk, E A Demina, V. B. Larionova, O P Trofimova, NA Probatova, NV Kokosadze, V M Sotnikov, YuE Ryabukhina, NV Volkova, EV Paramonova, EG Medvedovskaya

Publikováno v: Kliničeskaâ onkogematologiâ, Vol 10, Iss 4, Pp 443-452 (2017)

Aim. To assess the efficacy and toxicity of intensive 6 courses EACOPP-14 treatment with or without radiotherapy (RT) for advanced stages of Hodgkin's lymphoma (HL). Materials & Methods. From November 2009 to February 2015, 95 patients with advanced

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c406459b1b244839194bb5b97f7446a0
http://bloodjournal.ru/wp-content/uploads/2017/10/3_1.pdf

Loss of CD20 Expression in Follicular Lymphoma after Program Anti-Tumor Therapy Including Rituximab: Literature Data and Case Report

Autor: A. V. Mozhenkova, NA Kupryshina, E N Sorokin, NN Tupitsyn, EA Osmanov, NV Kokosadze, Gayane Tumyan, OM Volodina, VA Doronin, MA Frenkel, N. A. Falaleeva

Publikováno v: Kliničeskaâ onkogematologiâ, Vol 10, Iss 2, Pp 176-181 (2017)

It is the first description of a case of follicular lymphoma with a loss of CD20 antigen expression during the anti-tumor treatment including rituximab in the NN Blokhin Russian Cancer Research Center. The article discusses the tactics of further man

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de07506efaa89a29053e3fd6431a7a7b
https://doi.org/10.21320/2500-2139-2017-10-2-176-181

[Idiopathic multicentric Castleman's disease].

Autor: Vasilyev VI; Nasonova Research Institute of Rheumatology., Palshina SG; Nasonova Research Institute of Rheumatology., Pavlovskaya AI; Blokhin National Medical Research Center of Oncology., Kokosadze NV; Blokhin National Medical Research Center of Oncology., Chaltsev BD; Nasonova Research Institute of Rheumatology., Shornikova LA; Yevdokimov Moscow State University of Medicine and Dentistry.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2020 Jun 05; Vol. 92 (5), pp. 78-84. Date of Electronic Publication: 2020 Jun 05.

Diagnosis of IgG4 - related ophthalmic disease in a group of patients with various lesions of the eye and orbits.

Autor: Vasilyev VI; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Safonova TN; Research Institute of Eye Diseases, Moscow, Russia., Socol EV; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Probatova NA; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russian Federation, Moscow, Russia., Kokosadze NV; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russian Federation, Moscow, Russia., Pavlovskaya AI; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russian Federation, Moscow, Russia., Kovrigina AM; Hematology Research Center, Ministry of Health of Russian Federation, Moscow, Russia., Radenska-Lopovok SG; I.M. Sechenova 1 Moscow Medical University, Moscow, Russia., Gorodetsky VR; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Rodionova EB; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Palshina SG; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Aleksandrova EN; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Shornikova NS; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Gaiduk IV; A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2018 May 11; Vol. 90 (5), pp. 61-71.

[The differential diagnosis of Erdheim-Chester disease and IgG4-related diseases].

Autor: Vasilyev VI; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Sokol EV; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Kokosadze NV; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia, Moscow, Russia., Pavlovskaya AI; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia, Moscow, Russia., Komov DV; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia, Moscow, Russia., Palshina SG; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Mukhortova OV; A.N. Bakulev Research Center of Cardiovascular Surgery, Moscow, Russia., Safonova TN; Research Institute of Eye Diseases, Moscow, Russia.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2016; Vol. 88 (5), pp. 70-76.